Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	5HT_rcpt	HTR1A HTR2B	1.22e-04	9	35	2	IPR002231
Domain	PH	DOCK10 GRB10 PLCG2	8.92e-03	229	35	3	PF00169
Domain	PH	DOCK10 GRB10 PLCG2	1.50e-02	278	35	3	SM00233
Domain	PH_DOMAIN	DOCK10 GRB10 PLCG2	1.52e-02	279	35	3	PS50003
Domain	PH_domain	DOCK10 GRB10 PLCG2	1.53e-02	280	35	3	IPR001849
Domain	SH2	GRB10 PLCG2	1.53e-02	101	35	2	PF00017
Domain	SH2	GRB10 PLCG2	1.80e-02	110	35	2	SM00252
Domain	SH2	GRB10 PLCG2	1.83e-02	111	35	2	PS50001
Pubmed	Overexpression of CDC14B causes mitotic arrest and inhibits zygotic genome activation in mouse preimplantation embryos.	CDC14C CDC14B	1.10e-06	2	37	2	19923902
Pubmed	The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway.	CDC14C CDC14B	1.10e-06	2	37	2	21502810
Pubmed	Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein.	CDC14C CDC14B	1.10e-06	2	37	2	18547142
Pubmed	Early-onset aging and defective DNA damage response in Cdc14b-deficient mice.	CDC14C CDC14B	3.30e-06	3	37	2	21262768
Pubmed	5-Hydroxytryptamine 1A and 2B serotonin receptors in neurite outgrowth: involvement of early growth response protein 1.	HTR1A HTR2B	3.30e-06	3	37	2	24158140
Pubmed	Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription.	CDC14C CDC14B	3.30e-06	3	37	2	22355704
Pubmed	CDC14B acts through FZR1 (CDH1) to prevent meiotic maturation of mouse oocytes.	CDC14C CDC14B	3.30e-06	3	37	2	19129509
Pubmed	Cdc14A and Cdc14B Redundantly Regulate DNA Double-Strand Break Repair.	CDC14C CDC14B	3.30e-06	3	37	2	26283732
Pubmed	CDC14A phosphatase is essential for hearing and male fertility in mouse and human.	CDC14C CDC14B	6.60e-06	4	37	2	29293958
Pubmed	Expression of serotonin receptors 5-HT1A, 5-HT1B, 5-HT2B and 5-HT4 in ovary and in ovarian tumours.	HTR1A HTR2B	6.60e-06	4	37	2	22493371
Pubmed	Mis12 controls cyclin B1 stabilization via Cdc14B-mediated APC/CCdh1 regulation during meiotic G2/M transition in mouse oocytes.	CDC14C CDC14B	6.60e-06	4	37	2	32341029
Pubmed	An autoradiographic study of serotonergic receptors in a murine genetic model of anxiety-related behaviors.	HTR1A HTR2B	1.10e-05	5	37	2	8833759
Pubmed	Involvement of neurotransmitters in the action of growth hormone-releasing hormone antagonist on passive avoidance learning.	HTR1A HTR2B	8.53e-05	13	37	2	22640814
Pubmed	Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice.	HTR1A HTR2B	8.53e-05	13	37	2	22569571
Pubmed	Genetic evaluation of the serotonergic system in chronic fatigue syndrome.	HTR1A HTR2B	8.53e-05	13	37	2	18079067
Pubmed	Association study of the serotoninergic system in migraine in the Spanish population.	HTR1A HTR2B	1.67e-04	18	37	2	19455600
Pubmed	Meiosis-specific ZFP541 repressor complex promotes developmental progression of meiotic prophase towards completion during mouse spermatogenesis.	STRA8 DNTTIP1	1.67e-04	18	37	2	34075040
Pubmed	Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.	HTR1A HTR2B	1.86e-04	19	37	2	19095219
Pubmed	Npat-dependent programmed Sertoli cell proliferation is indispensable for testis cord development and germ cell mitotic arrest.	CASP8AP2 STRA8	1.86e-04	19	37	2	31084574
Pubmed	Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.	HTR1A PLCG2 HTR2B NRG3	2.86e-04	300	37	4	19086053
Pubmed	A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure.	HTR1A HTR2B	4.09e-04	28	37	2	19737523
Pubmed	Identification of cathepsin K as a novel marker of adiposity in white adipose tissue.	POGLUT3 MAN2A1	4.39e-04	29	37	2	12652657
Pubmed	CITGeneDB: a comprehensive database of human and mouse genes enhancing or suppressing cold-induced thermogenesis validated by perturbation experiments in mice.	GRB10 CMKLR1 IL18R1	5.07e-04	146	37	3	29688375
Pubmed	Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.	DIAPH2 NPEPPS DNTTIP1 DYRK2	5.63e-04	359	37	4	35559673
Pubmed	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	HTR1A NRG3	5.69e-04	33	37	2	24204828
Pubmed	Genome-scale RNAi screen for host factors required for HIV replication.	DCBLD1 ETV3 CMKLR1 IL18R1	5.75e-04	361	37	4	18976975
Pubmed	Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.	PPARA ALPK1	6.05e-04	34	37	2	15221005
Pubmed	5-hydroxytryptamine synthesized in the aorta-gonad-mesonephros regulates hematopoietic stem and progenitor cell survival.	HTR1A HTR2B	6.41e-04	35	37	2	28031476
Pubmed	SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.	PRPF31 PPIL2 POGLUT3 NPEPPS	6.83e-04	378	37	4	34315543
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	ETV3 GRB10 PRPF31 ALPK1 HIF1AN DNTTIP1	7.34e-04	1038	37	6	26673895
Pubmed	Genetic loci associated with circulating levels of very long-chain saturated fatty acids.	PPARA NPEPPS	9.23e-04	42	37	2	25378659
Pubmed	Accumulation of NCOA1 dependent on HERC3 deficiency transactivates matrix metallopeptidases and promotes extracellular matrix degradation in intervertebral disc degeneration.	PLCG2 NRG3	9.67e-04	43	37	2	36878279
Pubmed	BCAS2 regulates oocyte meiotic prophase I by participating in mRNA alternative splicing.	DIAPH2 STRA8	1.01e-03	44	37	2	38085152
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	PRPF31 TIMM44 BZW2 NPEPPS	1.03e-03	422	37	4	27342126
Cytoband	Ensembl 112 genes in cytogenetic band chr7p12	CDC14C GRB10	1.20e-03	63	37	2	chr7p12
Cytoband	Ensembl 112 genes in cytogenetic band chr6q22	DCBLD1 CLVS2	4.75e-03	127	37	2	chr6q22
GeneFamily	5-hydroxytryptamine receptors, G protein-coupled	HTR1A HTR2B	9.00e-05	13	20	2	170
GeneFamily	SH2 domain containing	GRB10 PLCG2	5.50e-03	101	20	2	741
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	DOCK10 GRB10	2.15e-02	206	20	2	682
ToppCell	TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4\|TCGA-Uvea / Sample_Type by Project: Shred V9	MAN2A1 HTR2B C12orf60 DYRK2	1.61e-05	184	37	4	9c56753e5e668be888662e4713cf4ce44e6c58fb
ToppCell	COVID-19-kidney-Glomerular_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GRB10 PLCG2 NRG3 IL18R1	1.98e-05	194	37	4	660535b492445063d965095a50e1e299ce04c50a
ToppCell	IPF-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	HTR2B NRG3 C12orf60 IL18R1	1.98e-05	194	37	4	e8a9005963704286bcc50785bda8d7d63ec001b1
ToppCell	LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_only / Treatment groups by lineage, cell group, cell type	DOCK10 ETV3 SLC24A4 IL18R1	2.14e-05	198	37	4	d205dfcfe1f20e1e21bf84759e723d9e6e610a5c
Drug	staurosporine; Down 200; 0.01uM; SKMEL5; HG-U133A	DOCK10 PRPF31 PPIL2 ALPK1 TIMM44 DYRK2	7.02e-07	196	37	6	508_DN
Drug	Photofrin	HGD HTR1A HTR2B	5.15e-06	21	37	3	CID000057166
Drug	amperozide	DIAPH2 HTR1A HTR2B	2.49e-05	35	37	3	CID000073333
Drug	butyranilide	HTR1A HTR2B	2.56e-05	5	37	2	CID000014323
Drug	ATC0175	HTR1A HTR2B	2.56e-05	5	37	2	CID009934032
Drug	Methysergide	HTR1A HTR2B	2.56e-05	5	37	2	DB00247
Drug	Org 6997	HTR1A HTR2B	2.56e-05	5	37	2	CID000171831
Drug	SB221284	HTR1A HTR2B	2.56e-05	5	37	2	CID000443389
Drug	Dmipap	HTR1A HTR2B	3.84e-05	6	37	2	CID000126620
Drug	BrAcTFMPP	HTR1A HTR2B	3.84e-05	6	37	2	CID000146887
Drug	compound 31	HTR1A PPARA HTR2B	4.34e-05	42	37	3	CID005288687
Drug	ondansetron	HTR1A ALPK1 HTR2B	5.00e-05	44	37	3	CID000004595
Drug	Kytril	HTR1A ALPK1 HTR2B	5.35e-05	45	37	3	CID000003510
Drug	Eletriptan	HTR1A HTR2B	5.37e-05	7	37	2	DB00216
Drug	1192U90	HTR1A HTR2B	5.37e-05	7	37	2	CID000127912
Drug	SC 53116	HTR1A HTR2B	5.37e-05	7	37	2	CID000132337
Drug	AC 695	HTR1A PLCG2 HTR2B	6.10e-05	47	37	3	CID000004885
Drug	chloroamphetamine	HTR1A HTR2B	7.15e-05	8	37	2	CID000541822
Drug	BW501	HTR1A HTR2B	7.15e-05	8	37	2	CID000172195
Drug	SB215,505	HTR1A HTR2B	7.15e-05	8	37	2	CID006603999
Drug	AC1L2ZOK	HTR1A HTR2B	7.15e-05	8	37	2	CID000131724
Drug	medifoxamine	HTR1A HTR2B	7.15e-05	8	37	2	CID000036109
Drug	SB 216641	HTR1A HTR2B	7.15e-05	8	37	2	CID003292447
Drug	amesergide	HTR1A HTR2B	7.15e-05	8	37	2	CID000060740
Drug	Ro 04-6790	HTR1A HTR2B	9.18e-05	9	37	2	CID005312145
Drug	CHEBI:334542	HTR1A HTR2B	9.18e-05	9	37	2	CID010884046
Drug	CHEBI:334375	HTR1A HTR2B	9.18e-05	9	37	2	CID010476504
Drug	seganserin	HTR1A HTR2B	1.15e-04	10	37	2	CID000071767
Drug	LY344864	HTR1A HTR2B	1.15e-04	10	37	2	CID005311097
Drug	RS-127445	HTR1A HTR2B	1.40e-04	11	37	2	CID000196968
Drug	homophthalimide	HTR1A HTR2B	1.40e-04	11	37	2	CID000349435
Drug	BRL15572	HTR1A HTR2B	1.68e-04	12	37	2	CID003654103
Drug	S 14506	HTR1A HTR2B	1.68e-04	12	37	2	CID000131905
Drug	LSD tartrate	HTR1A HTR2B	1.68e-04	12	37	2	CID000159828
Drug	sergolexole	HTR1A HTR2B	1.68e-04	12	37	2	CID000060262
Drug	ocaperidone	HTR1A HTR2B	1.68e-04	12	37	2	CID000071351
Drug	6-MBOA	DIAPH2 ALPK1	1.98e-04	13	37	2	CID000010772
Drug	cianopramine	HTR1A HTR2B	1.98e-04	13	37	2	CID000048126
Drug	AC1O5P4A	HTR1A HTR2B	1.98e-04	13	37	2	CID005464200
Drug	MDL 73005EF	HTR1A HTR2B	1.98e-04	13	37	2	CID000060769
Drug	2,5-dimethoxy-4-methylamphetamine	HTR1A HTR2B	1.98e-04	13	37	2	CID000085874
Drug	Lisuride	HTR1A HTR2B	2.31e-04	14	37	2	DB00589
Drug	xylamidine	HTR1A HTR2B	2.31e-04	14	37	2	CID000022950
Drug	Pramipexole	HTR1A HTR2B	2.31e-04	14	37	2	DB00413
Drug	compound 4d	HTR1A HTR2B	2.31e-04	14	37	2	CID000448577
Drug	Ropinirole	HTR1A HTR2B	2.31e-04	14	37	2	DB00268
Drug	L-694,247	HTR1A HTR2B	2.31e-04	14	37	2	CID000132059
Drug	YM348	HTR1A HTR2B	2.31e-04	14	37	2	CID003045225
Drug	McN5652	HTR1A HTR2B	2.31e-04	14	37	2	CID000146919
Drug	Cabergoline	HTR1A HTR2B	2.66e-04	15	37	2	DB00248
Drug	dotarizine	HTR1A HTR2B	2.66e-04	15	37	2	CID000055285
Drug	altanserin	HTR1A HTR2B	2.66e-04	15	37	2	CID003033676
Drug	Apomorphine	HTR1A HTR2B	2.66e-04	15	37	2	DB00714
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A	DIAPH2 GRB10 PPIL2 DYRK2	2.71e-04	194	37	4	3431_DN
Drug	Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; HL60; HG-U133A	PRPF31 PPIL2 TIMM44 HIF1AN	2.76e-04	195	37	4	2000_DN
Drug	Famprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	PPIL2 PLCG2 ALPK1 CDC14B	2.82e-04	196	37	4	6029_DN
Drug	Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; HL60; HT_HG-U133A	PPIL2 PPARA HTR2B CDC14B	2.82e-04	196	37	4	2381_UP
Drug	aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA	DIAPH2 GRB10 ALPK1 CDC14B	2.87e-04	197	37	4	1042_UP
Drug	Methacholine chloride [62-51-1]; Up 200; 20.4uM; PC3; HT_HG-U133A	DIAPH2 PPIL2 PLCG2 ALPK1	2.87e-04	197	37	4	5773_UP
Drug	DAPH; Down 200; 10uM; MCF7; HG-U133A	PPIL2 MAN2A1 HIF1AN DYRK2	2.87e-04	197	37	4	624_DN
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A	DIAPH2 GRB10 CDC14B HIF1AN	2.87e-04	197	37	4	3436_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	GRB10 PPIL2 TIMM44 HIF1AN	2.93e-04	198	37	4	1650_DN
Drug	GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; HL60; HG-U133A	DOCK10 PRPF31 PPIL2 DYRK2	2.93e-04	198	37	4	1625_DN
Drug	Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A	PPIL2 PPARA ALPK1 CDC14B	2.93e-04	198	37	4	4838_DN
Drug	Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A	GRB10 PRPF31 PPIL2 CDC14B	2.93e-04	198	37	4	3551_DN
Drug	buspirone	HTR1A ALPK1 HTR2B	2.98e-04	80	37	3	CID000002477
Drug	sumatriptan	HTR1A ALPK1 HTR2B	2.98e-04	80	37	3	CID000005358
Drug	Pyrilamine maleate [59-33-6]; Down 200; 10uM; HL60; HG-U133A	PRPF31 PPIL2 ALPK1 TIMM44	2.98e-04	199	37	4	1568_DN
Drug	Rimexolone [49697-38-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A	GRB10 PPIL2 CDC14B HIF1AN	2.98e-04	199	37	4	5517_UP
Drug	Condelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	DIAPH2 PPIL2 PPARA DYRK2	2.98e-04	199	37	4	6357_UP
Drug	isamoltane	HTR1A HTR2B	3.04e-04	16	37	2	CID000127403
Drug	piperazine dihydrochloride	HTR1A HTR2B	3.04e-04	16	37	2	CID000008893
Drug	Benzamides	HTR1A PPARA	3.04e-04	16	37	2	ctd:D001549
Drug	5-nonyloxytryptamine	HTR1A HTR2B	3.04e-04	16	37	2	CID000001797
Drug	1-(3-chlorophenyl)piperazine	HTR1A HTR2B	3.04e-04	16	37	2	ctd:C015068
Drug	WY-14643; Up 200; 100uM; PC3; HG-U133A	DIAPH2 DOCK10 CMKLR1 DYRK2	3.04e-04	200	37	4	481_UP
Drug	Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A	DIAPH2 DOCK10 PLCG2 CDC14B	3.04e-04	200	37	4	2648_UP
Drug	Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A	GRB10 PPIL2 ALPK1 TIMM44	3.04e-04	200	37	4	7463_UP
Drug	2,5-dimethoxy-4-bromoamphetamine	HTR1A HTR2B	3.44e-04	17	37	2	CID000062064
Drug	5-methyltryptamine	HTR1A HTR2B	3.44e-04	17	37	2	CID000015760
Drug	psilocybin	HTR1A HTR2B	3.44e-04	17	37	2	CID000010624
Drug	Pergolide	HTR1A HTR2B	3.44e-04	17	37	2	DB01186
Drug	zatosetron	HTR1A HTR2B	3.44e-04	17	37	2	CID000060763
Drug	psilocin	HTR1A HTR2B	3.87e-04	18	37	2	CID000004980
Drug	SB 242084	HTR1A HTR2B	3.87e-04	18	37	2	CID003644637
Drug	Bromocriptine	HTR1A HTR2B	3.87e-04	18	37	2	DB01200
Drug	DP-5-CT	HTR1A HTR2B	3.87e-04	18	37	2	CID000156314
Drug	mescaline	HTR1A HTR2B	3.87e-04	18	37	2	CID000004076
Drug	RS 102221	HTR1A HTR2B	3.87e-04	18	37	2	CID003693566
Drug	benzoctamine	HTR1A HTR2B	3.87e-04	18	37	2	CID000028425
Drug	cyclobutane	HTR1A PPARA	3.87e-04	18	37	2	CID000009250
Drug	pAPP	HTR1A HTR2B	3.87e-04	18	37	2	CID000121930
Drug	DuP 734	HTR1A HTR2B	3.87e-04	18	37	2	CID000121967
Drug	metolachlor	DIAPH2 PLCG2 DYRK2	3.94e-04	88	37	3	CID000004169
Drug	phenylethylamine	HGD HTR1A HTR2B	4.07e-04	89	37	3	CID000001001
Drug	MDL 11,939	HTR1A HTR2B	4.32e-04	19	37	2	CID000071781
Drug	1-PP	HTR1A HTR2B	4.32e-04	19	37	2	CID000088747
Drug	femoxitine	HTR1A HTR2B	4.32e-04	19	37	2	CID000043103
Drug	tiospirone	HTR1A HTR2B	4.32e-04	19	37	2	CID000055751
Drug	NSC186067	HTR1A HTR2B	4.32e-04	19	37	2	CID000004140
Disease	generalized anxiety disorder (implicated_via_orthology)	HTR1A HTR2B	4.03e-05	8	36	2	DOID:14320 (implicated_via_orthology)
Disease	kynurenic acid measurement	BZW2 DYRK2	1.12e-04	13	36	2	EFO_0010506
Disease	diet measurement, fasting blood insulin measurement	HTR1A NRG3	3.29e-04	22	36	2	EFO_0004466, EFO_0008111
Disease	diet measurement, HOMA-IR	HTR1A NRG3	3.60e-04	23	36	2	EFO_0004501, EFO_0008111
Disease	fasting blood glucose measurement	DCBLD1 GRB10 NRG3 SLC24A4	4.04e-04	287	36	4	EFO_0004465
Disease	Schizophrenia	GRB10 HTR1A PPARA NRG3 IL18R1 CLVS2	6.38e-04	883	36	6	C0036341
Disease	nicotine withdrawal symptom count	DOCK10 NRG3	8.40e-04	35	36	2	EFO_0009263
Disease	chronic kidney disease, diabetic nephropathy	NRG3 SLC24A4	8.88e-04	36	36	2	EFO_0000401, EFO_0003884
Disease	very long-chain saturated fatty acid measurement	PPARA NPEPPS	1.33e-03	44	36	2	EFO_0006796
Disease	interstitial lung disease	HTR1A NRG3	3.04e-03	67	36	2	EFO_0004244
Disease	schizophrenia (implicated_via_orthology)	PPARA NRG3	3.13e-03	68	36	2	DOID:5419 (implicated_via_orthology)
Disease	white matter lesion progression measurement	HTR1A NRG3	3.41e-03	71	36	2	EFO_0007746
Disease	Cardiac Hypertrophy	PPARA HTR2B	4.52e-03	82	36	2	C1383860
Disease	Cardiomegaly	PPARA HTR2B	4.52e-03	82	36	2	C0018800
Disease	Drug toxicity	PPARA HTR2B	4.74e-03	84	36	2	C0013221
Disease	Adverse reaction to drug	PPARA HTR2B	4.74e-03	84	36	2	C0041755
Disease	serum iron measurement	PLCG2 SLC24A4	4.96e-03	86	36	2	EFO_0006332
Disease	lymphocyte:monocyte ratio	DOCK10 GRB10 CMKLR1	5.18e-03	288	36	3	EFO_0600088
Disease	age-related hearing impairment	DOCK10 GRB10 HTR1A	7.16e-03	324	36	3	EFO_0005782

Protein segments in the cluster

Peptide	Gene	Start	Entry
FMKAFQKIVVLFYKA	BZW2	356	Q9Y6E2
YFRNPMAENSKFFKK	HTR2B	416	P41595
VKKAMQYGFLNFNSF	CDC14B	186	O60729
FTYKFNFNKLVMPNY	ETV3	111	P41162
YKLIQCLKAFMNNKF	DIAPH2	231	O60879
KNYMKFKAKFSLIQF	CASP8AP2	1051	Q9UKL3
VKKAMQYGFLNFNSF	CDC14C	156	A4D256
FVSMSKNDYEKFKNN	ALPK1	246	Q96QP1
KYNVKMQAFFTVKQK	SLC24A4	246	Q8NFF2
KFNVSNFYHVKNNMK	PPIL2	166	Q13356
MFCAAFYFKSKKQAK	NRG3	376	P56975
YFFQMKNYTQKWKLN	IL18R1	96	Q13478
KFNFNAYKKEMASFF	PNLIPRP3	261	Q17RR3
FDYMNSQSKFKVKIQ	MAN2A1	446	Q16706
LYYDEKKMANFQNFK	HIF1AN	101	Q9NWT6
YFLNKNKMQEKLFKE	KMT5B	166	Q4FZB7
MKNLKNVFVNFKCYL	FSIP2	686	Q5CZC0
QFHLFYKKLMFEQQK	PLCG2	201	P16885
DFKKGMNMYLTKFQQ	NPEPPSL1	456	A6NEC2
LLYFFMRKNFEFNKQ	DOCK10	1586	Q96BY6
AYFNKDFQNAFKKII	HTR1A	401	P08908
RKNYAKYEFFKNPMN	GRB10	246	Q13322
NFNFYVKSFVMNFKN	DCBLD1	336	Q8N8Z6
MNLYELIKKNKFQGF	DYRK2	306	Q92630
DFKKGMNMYLTKFQQ	NPEPPS	456	P55786
KYNLKNFMVINSVAF	HGD	276	Q93099
YEAYLKNFNMNKVKA	PPARA	211	Q07869
KKMFGKNQVINKVYF	OR5T2	341	Q8NGG2
EEKFQLYMQIINFFK	STRA8	281	Q7Z7C7
YVFMGQDFKKFKVAL	CMKLR1	316	Q99788
KNNSYIKDFFEQMLK	C12orf60	51	Q5U649
FEYRQQNLDMFKSFK	CLVS2	76	Q5SYC1
AKLMGFFDFFKYKYQ	POGLUT3	356	Q7Z4H8
EIQTVFNKYMKFFQK	DNTTIP1	81	Q9H147
FNKYMKFFQKAALNV	DNTTIP1	86	Q9H147
NQKYFSSMAEFLKVK	PRPF31	476	Q8WWY3
NNVVFNRFFEMKMKY	TIMM44	251	O43615
FSIRDNFMQQKAFKY	XKR3	151	Q5GH77
QDSKKFLKIMFSYNN	TRBV3-1	56	A0A576